Lotion, Cream, Gel, and Ointment Similarly Effective for Childhood Eczema

THURSDAY, June 2, 2022 (HealthDay News) -- There are no differences in effectiveness between the four main types of moisturizers for childhood eczema, according to a study published online May 23 in The Lancet Child & Adolescent Health.
Matthew J. Ridd, Ph.D., from the University of Bristol in the United Kingdom, and colleagues compared the clinical effectiveness and safety of the four main emollient types. Children (aged 6 months to 12 years) with eczema were randomly assigned to lotions (137 children), creams (140 children), gels (135 children), and ointments (138 children).
The researchers observed no difference in eczema severity between emollient types over 16 weeks. Results remained unchanged even with multiple imputation, sensitivity, and subgroup analyses. There were also no differences seen in total number of adverse events between the treatment groups (36, 39, 40, and 35 percent for lotions, creams, gels, and ointments, respectively). However, stinging was less common with ointments (9 percent) compared with lotions (20 percent), creams (17 percent), and gels (19 percent).
"A study of this type has been long overdue. It has not been in the interest of the manufacturers to directly compare types of moisturizer in the way we have done in this trial," Ridd said in a statement. "Our findings challenge conventions about how often moisturizers need to be applied, which types are less likely to cause problems and which patients should be recommended certain types."
Related Posts
Las bebidas azucaradas aumentan el riesgo de enfermedad y cáncer de hígado de las mujeres
MIÉRCOLES, 9 de agosto de 2023 (HealthDay News) -- Hay muchos motivos para...
COVID Shots’ Effect Fades, But Boosters Bring Protection Back: Study
MONDAY, Sept. 12, 2022 (HealthDay News) -- Updated COVID-19 booster shots that...
Se estanca el progreso contra los mortinatos en EE. UU.
MARTES, 15 de noviembre de 2022 (HealthDay News) -- Las tasas de mortinatos de...
La vacunación más una infección postvacunación podría ofrecer una ‘superinmunidad’ ante las nuevas variantes
VIERNES, 17 de diciembre de 2021 (HealthDay News) -- Las infecciones...
